Trident Texofab Board Approves Un-Audited Q1 FY27 Results

Trident Texofab Ltd announced the outcome of its Board Meeting held on August 10, 2026. The Board took on record the Un-Audited Financial Results for the quarter ended June 30, 2026, along with the Limited Review Report from the statutory auditor. The company also noted various compliances made during the quarter. Additionally, the Board accepted the resignation of its statutory auditor, M/s. Shah Kairash and Associates LLP, effective August 10, 2026, and will consider appointing a new auditor to fill the casual vacancy. M/s. PritAgrawal & Co. was appointed as the Internal Auditor for the financial year 2026-27.